供货周期: | 7天 |
品牌: | 爱必信 |
型号: | 98% |
货号: | abs821696 |
CAS号: | 2226735-55-1 |
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:GSK'547 产品别名:见爱必信官网 英文别名:GSK'547 靶点:RIP Kinase CAS:2226735-55-1 纯度:98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder) 描述:GSK547, a highly selective and potent RIP1 inhibitor, inhibits macrophage-mediated adaptive immune tolerance in pancreatic cancer. 溶解性: 体外研究: GSK547 (0.1-100000 nM; 24 hours) pretreats L929 cells with recombinant TNFα and zVAD at various doses for 30 min, then cell death is induced with an IC50 of 32 nM after 24 hours.GSK547 up-regulates STAT1 signaling in bone marrow-derived macrophages (BMDM).Cell Viability AssayCell Line:L929 cells (Mouse L-cells NCTC 929)Concentration:0.1 nM; 10 nM; 1000 nM; 100000 nMIncubation Time:24 hoursResult:Reduced viability of L929 cells after co-treatment with TNFα and zVAD with an IC50 of 32 nM. 体内研究:GSK547 (0.1-100000 nM; 24 hours) pretreats L929 cells with recombinant TNFα and zVAD at various doses for 30 min, then cell death is induced with an IC50 of 32 nM after 24 hours.GSK547 up-regulates STAT1 signaling in bone marrow-derived macrophages (BMDM).Cell Viability AssayCell Line:L929 cells (Mouse L-cells NCTC 929)Concentration:0.1 nM; 10 nM; 1000 nM; 100000 nMIncubation Time:24 hoursResult:Reduced viability of L929 cells after co-treatment with TNFα and zVAD with an IC50 of 32 nM.
产品信息订购:
|
相关产品
详细地址
关注
拨打电话
留言咨询